Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term T-Lymphocytes. Found 28 abstracts

no pagination
Wang M, Munoz J, Goy A, Locke FL, Jacobson CA, Hill BT, Timmerman JM, Holmes H, Jaglowski S, Flinn IW, McSweeney PA, Miklos DB, Pagel JM, Kersten MJ, Milpied N, Fung H, Topp MS, Houot R, Beitinjaneh A, Peng W, Zheng L, Rossi JM, Jain RK, Rao AV, Reagan PM. KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma. The New England journal of medicine. 2020 Apr 02;382(14):1331-42.
Shen H, Wu N, Nanayakkara G, Fu H, Yang Q, Yang WY, Li A, Sun Y, Drummer Iv C, Johnson C, Shao Y, Wang L, Xu K, Hu W, Chan M, Tam V, Choi ET, Wang H, Yang X. Co-signaling receptors regulate T-cell plasticity and immune tolerance. Frontiers in bioscience (Landmark edition). 2019 Jan;24:96-132.   PMCID: PMC6309335
Huang Q, He S, Tian Y, Gu Y, Chen P, Li C, Huang J, Liu Y, Yu H, Jin M, Hu S, Tong Q, Ma A, Jin J, Hexner E, Fung H, Reshef R, Zhang Y, Zhang Y. Hsp90 inhibition destabilizes Ezh2 protein in alloreactive T cells and reduces graft-versus-host disease in mice. Blood. 2017 May 18;129(20):2737-48.   PMCID: PMC5437825
Moy RH, Huffman AP, Richman LP, Crisalli L, Wang XK, Hoxie JA, Mick R, Emerson SG, Zhang Y, Vonderheide RH, Porter DL, Reshef R. Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis. Blood. 2017 Feb 16;129(7):906-16.   PMCID: PMC5314813
Somech R, Lev A, Lee YN, Simon AJ, Barel O, Schiby G, Avivi C, Barshack I, Rhodes M, Yin J, Wang M, Yang Y, Rhodes J, Marcus N, Garty BZ, Stein J, Amariglio N, Rechavi G, Wiest DL, Zhang Y. Disruption of Thrombocyte and T Lymphocyte Development by a Mutation in ARPC1B. J Immunol. 2017 Nov 10;199(12):4036-45.   PMCID: PMC5726601
Ganea D, Hooper KM, Kong W. The neuropeptide vasoactive intestinal peptide: direct effects on immune cells and involvement in inflammatory and autoimmune diseases. Acta Physiol (Oxf). 2015 Feb;213(2):442-52.   PMCID: PMC4484298
Mantia-Smaldone G, Ronner L, Blair A, Gamerman V, Morse C, Orsulic S, Rubin S, Gimotty P, Adams S. The immunomodulatory effects of pegylated liposomal doxorubicin are amplified in BRCA1--deficient ovarian tumors and can be exploited to improve treatment response in a mouse model. Gynecol Oncol. 2014 Jun;133(3):584-90.
Smeets MF, Wiest DL, Izon DJ. Fli-1 regulates the DN2 to DN3 thymocyte transition and promotes gammadelta T-cell commitment by enhancing TCR signal strength. Eur J Immunol. 2014 Sep;44(9):2617-24.
Obeid E, Nanda R, Fu YX, Olopade OI. The role of tumor-associated macrophages in breast cancer progression (review). Int J Oncol. 2013 Jul;43(1):5-12.   PMCID: PMC3742164
Tchou J, Wang LC, Selven B, Zhang H, Conejo-Garcia J, Borghaei H, Kalos M, Vondeheide RH, Albelda SM, June CH, Zhang PJ. Mesothelin, a novel immunotherapy target for triple negative breast cancer. Breast Cancer Res Treat. 2012 Jun;133(2):799-804.
Lee SY, Stadanlick J, Kappes DJ, Wiest DL. Towards a molecular understanding of the differential signals regulating alphabeta/gammadelta T lineage choice. Seminars in immunology. 2010 Aug;22(4):237-46.   PMCID: PMC2906684
Borghaei H, Smith MR, Campbell KS. Immunotherapy of cancer. European journal of pharmacology. 2009 Dec 25;625(1-3):41-54.   PMCID: PMC2783916
Kiefer K, Oshinsky J, Kim J, Nakajima PB, Bosma GC, Bosma MJ. The catalytic subunit of DNA-protein kinase (DNA-PKcs) is not required for Ig class-switch recombination. Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2843-8.
Laport GG, Levine BL, Stadtmauer EA, Schuster SJ, Luger SM, Grupp S, Bunin N, Strobl FJ, Cotte J, Zheng Z, Gregson B, Rivers P, Vonderheide RH, Liebowitz DN, Porter DL, June CH. Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation. Blood. 2003 Sep 15;102(6):2004-13.
Schlienger K, Chu CS, Woo EY, Rivers PM, Toll AJ, Hudson B, Maus MV, Riley JL, Choi Y, Coukos G, Kaiser LR, Rubin SC, Levine BL, Carroll RG, June CH. TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients. Clin Cancer Res. 2003 Apr;9(4):1517-27.
Shalaby WS, Yeh H, Woo E, Hendren S, Corbett JT, Gray H, June CH, Shalaby SW. Development of novel substrates for tumor immunotherapy. J Control Release. 2003 Aug 28;91(1-2):209-24.
Vonderheide RH, June CH. A translational bridge to cancer immunotherapy: exploiting costimulation and target antigens for active and passive T cell immunotherapy. Immunol Res. 2003 Jan;27(2-3):341-56.
Zhang H, Merchant MS, Chua KS, Khanna C, Helman LJ, Telford B, Ward Y, Summers J, Toretsky J, Thomas EK, June CH, Mackall CL. Tumor expression of 4-1BB ligand sustains tumor lytic T cells. Cancer Biol Ther. 2003 Sep;2(5):579-86.
Bosma GC, Kim J, Urich T, Fath DM, Cotticelli MG, Ruetsch NR, Radic MZ, Bosma MJ. DNA-dependent protein kinase activity is not required for immunoglobulin class switching. J Exp Med. 2002 Dec 02;196(11):1483-95.
Hayes SM, Laky K, El-Khoury D, Kappes DJ, Fowlkes BJ, Love PE. Activation-induced modification in the CD3 complex of the gammadelta T cell receptor. J Exp Med. 2002 Nov 18;196(10):1355-61.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term T-Lymphocytes

T-Lymphocytes immunology metabolism genetics Mice Female therapy Human Male Adult Lymphocyte Activation Immunotherapy Aged Non-US Gov't Support Middle Aged prevention & control therapeutic use Dendritic Cells Flow Cytometry CD3 Antigens SCID Mice Adoptive Transfer pharmacology deficiency pathology Signal Transduction Hematopoietic Stem Cell Transplantation chemistry Neoplasms Tumor Cell Line Antigen Receptors-T-Cell-gamma-delta methods Inbred BALB C Mice cytology adverse effects drug effects drug therapy Ovarian Neoplasms Antigen Receptors-T-Cell blood T cells Inbred C57BL Mice Animal CD28 Antigens Breast Neoplasms Macrophages Graft vs Host Disease Immune Tolerance transplantation Adolescent analogs & derivatives B-Lymphocytes Antigen Receptors-T-Cell-alpha-beta Immunoglobulin Class Switching antagonists & inhibitors Genetic Recombination Recurrence physiology analysis Homologous Transplantation Neoplasm Antigens Combined Modality Therapy Chimeric Antigen Receptors Tumor-Infiltrating Lymphocytes Bone Neoplasms C-Type Lectins Lysine Actin Cytoskeleton Lymphocytosis Spleen Methylation classification tolerogenic dendritic cells Nuclear Proteins T-cell differentiation Lymphopoiesis Toll-Like Receptors CD19 Antigens Radioimmunotherapy gammadelta T cells Vascular Endothelial Growth Factor A Breeding Polymerization Survival Analysis Extracellular Matrix Fatal Outcome Gene Expression Profiling Fli-1 Ovarian cancer Genotype innate immunity Cytotoxic T-Lymphocytes neuropeptides Electron Microscopy Remission Induction Consanguinity Mantle-Cell Lymphoma Pancreatitis-Associated Proteins DNA Repair Preschool Child secretion Infant Catalytic Domain mortality Actin-Related Protein 2-3 Complex Adoptive Immunotherapy Enhancer of Zeste Homolog 2 Protein Mononuclear Leukocytes Immunoglobulin A Tumor Biomarkers Animal Disease Models Cellular Immunity Young Adult Carrier Proteins Follow-Up Studies Autoimmune Diseases Histones Progesterone Receptors DNA-Binding Proteins Proto-Oncogene Protein c-fli-1 Enzyme-Linked Immunosorbent Assay Brca biosynthesis Treatment Outcome Resorcinols Cultured Cells Frameshift Mutation V(D)J Recombination Neuropeptides vasoactive intestinal peptide CCR5 Receptor Antagonists CD40 Ligand Neoplastic Gene Expression Regulation US Gov't Support-PHS Glycosylation Immunologic Deficiency Syndromes Immunoglobulin G Cell Death Cell Survival Immunoglobulin Genes Pedigree Antineoplastic Antibiotics Multiprotein Complexes CD40 Antigens Thymus Gland Protein Domains Ligands Cytarabine Neoplasm Transplantation Antineoplastic Combined Chemotherapy Protocols
Last updated on Wednesday, August 12, 2020